# Diakonos Oncology

Source: https://onco.cc/companies/diakonos-oncology/  
OnCo record `diakonos-oncology` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Diakonos Oncology makes dendritic cell therapies from a patient's own cells, with trials under way in glioblastoma, pancreatic cancer and melanoma.

## Summary

Diakonos Oncology develops patient-derived dendritic cell vaccines that present the patient's own tumour antigens to the immune system, and is running clinical trials in glioblastoma, pancreatic cancer and melanoma. Access is through trial enrolment.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Tags: ctgov-sponsor; fcct-directory
- HQ: United States (city not published)
- Type: cell-therapy
- Website: https://www.diakonosoncology.com/

## Sources

- Official website: https://www.diakonosoncology.com/
- Listed on Future of Cancer Care Today (Sijbrandij Foundation): https://sijbrandijfoundation.org/fcct

## Connected records

- cancers: [Glioma & glioblastoma](https://onco.cc/cancers/glioblastoma/), [Melanoma](https://onco.cc/cancers/melanoma/), [Pancreatic ductal adenocarcinoma](https://onco.cc/cancers/pancreatic/)
- technologies: [Dendritic cell vaccines](https://onco.cc/technologies/dendritic-cell-vaccines/)
- drugs: [DOC1021](https://onco.cc/drugs/doc1021/)
- trials: [DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma](https://onco.cc/trials/nct07288112/), [DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)](https://onco.cc/trials/nct06805305/)

---
JSON: https://onco.cc/api/v1/entities/diakonos-oncology.json